References
- Kay S R. Positive and negative syndromes in schizophrenia. Assessment and Research. Brunner/Mazel, New York 1991, (Clinical and Experimental Psychiatry Monograph NO. 5)
- Johnstone E C, Owens D GC, Friht C D, Crow T J. The relative stability of positive and negative features in chronic schizophrenia. Br J Psychiatry 1987; 150: 60–4
- Pogue-Geile M F, Zubin J. Negative symptomatology in schizophrenia: A conceptual and empirical review. Int J Mental Health 1988; 16–3; 45
- Gerlach J. New antipsychotics: classification, efficacy and adverse effects. Schizophr Bull 1991; 2: 289–309
- Pierce P A, Peroutka S J. The 5-hydroxy tryptamine receptor families. Semin Neurosci 1989; 1: 145–53
- Meltzer H Y. Clinical studies on the mechanism of action of clozapine: the dopamine - serotonin hypothesis of schizophrenia. Psychopharmacology 1989; 99: 18–27
- Marder S R. Risperidone: efficacy on positive and negative symptoms. Paper presented at the 1st international Risperidone investigator meeting, Paris, 1992